AKT1 and melanoma: In the melanoma, hinokitiol could suppress the expression of heparanase through lowering the phosphorylation of protein kinase B (Akt) and ERK, inhibiting the expression and activity of MMP-2/9 simultaneously (Huang et al., 2015; Wu et al., 2020).